Clinical Trials Directory

Trials / Unknown

UnknownNCT00363792

Effect of GTN and Diamox Measured by BOLD-Response.

The Effect of Glyceryl Trinitrate and Diamox on Blood-Oxygenation-Level-Dependent.Signal (BOLD-Signal) and Cerebral Haemodynamics With the Use of a 3-Tesla MRI-Scan.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (planned)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

In healthy subjects different cerebral haemodynamic values wished to be determined after infusion of the NO donor Glyceryl trinitrate (GTN) and Diamox. The different values we wish to determine are: * Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation. * Changes in the diameter of a. cerebri media. * Changes in the regional and global cerebral blodd flow (CBF) with the help of the arterial Spin labeling (ASL) method.

Detailed description

Experimental headache models give a unike opportunity to study pathophysiological mechanisms of prim. headache types such as migraine. Previous studies have used different methods that have had limitations and none of them have had the opportunity to study neuronal activation. But that is possible with the application of functional magnetic resonance (fMRI). Before we apply fMRI to our experimental headache models it is needed to determine how the BOLD response is influenced and changed by the infusion of different drugs such as the NO donor Glyceryl Trinitrate (GTN) and Diamox (acetazolamide). It is known that GTN causes dilation of the cerebral arteries without having any effect on the regional cerebral blood flow. It is not known what effect GTN has on the BOLD response. Diamox (azetazolamide) increases the CBF but it is uncertain what effect the drug has on the BOLD response. Previous studies disagree gravely on this point. In this study we will be giving infusion of GTN and Diamox in healty subjects to determine: * Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation. * Changes in the diameter of a. cerebri media. * Changes in the regional and global cerebral blodd flow (CBF) with the help of the arterial Spin labeling (ASL) methode. For the study we will be using a 3-Tesla MRI-scan.

Conditions

Interventions

TypeNameDescription
DRUGGlyceryl trinitrate, azetazolamide

Timeline

Completion
2007-05-01
First posted
2006-08-15
Last updated
2006-08-15

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00363792. Inclusion in this directory is not an endorsement.